STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

The Readout Loud
Claim This Podcastby STAT
Podcast Authority
Beta
Podcast Overview
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Language
🇺🇲
Publishing Since
3/2/2018
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for The Readout Loud
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

May 28, 2026
403: Biotech exec Jeremy Levin on the industry's strategic turning point
Biotech executive Jeremy Levin discusses the industry's current strategic turning point in this interview.

May 21, 2026
402: Guarding biotech from China and big bets in longevity
STAT's Adam Feuerstein and Rebecca Robbins interview BridgeBio CEO Neil Kumar and Retro Biosciences CEO Joe Betts-LaCroix about biotech innovation, longevity research, and geopolitical threats to the industry.

May 14, 2026
401: Makary’s departure and Cassidy’s tenuous Senate seat
This week’s episode of “The Readout LOUD” is all about health politics. We bring on FDA reporter Lizzy Lawrence to discuss Makary’s departure — why he is leaving, which of his policies will stick, and what we know about his acting replacement, Kyle Diamantas. Washington correspondent Chelsea Cirruzzo also joins us to discuss a closely tracked Republican Senate primary election this weekend. Bill Cassidy, chair of the Senate health committee, is up against two upstart rivals, including a Trump-backed candidate. The outcome of the primary could have far reaching implications for Trump’s health care agenda.
408 total episodes available with 111 transcripts
Recent guests on The Readout Loud
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Jeremy Levin
Guest
Joe Betts-LaCroix
Guest
Stelios Papadapolous
Guest
Damian Garde
Guest
Cameron Turtle
Guest
Jared Holz
Guest
Katie Palmer
Guest
Lizzy Lawrence
Guest
Matthew Herper
Guest
Stephen Hoge
Guest
Jesse Goodman
Guest
Jason Mast
Guest
Similar Podcasts
Discover related shows you might enjoy

BioCentury This Week
BioCentury

Biotech Hangout
Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

The Long Run with Luke Timmerman
Timmerman Report

Business Of Biotech
Ben Comer

The BioCentury Show
BioCentury

a16z Podcast
Andreessen Horowitz

Hard Fork
The New York Times

The AI Breakdown: Daily Artificial Intelligence News and Discussions
Nathaniel Whittemore

The Top Line
Fierce Life Sciences

Biotech 2050 Podcast
Biotech 2050

Ground Truths
Eric Topol

Nature Podcast
Springer Nature Limited

In Machines We Trust
MIT Technology Review

Tradeoffs
Tradeoffs

KFF Health News' 'What the Health?'
KFF Health News
Deep-dive analytics for The Readout Loud
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is The Readout Loud?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.